Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 36 citing articles:

Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review
Huijun Chen, Xiaoli Zhang, Ge Lin, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 12
Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
Rodolfo Pedro Rothlin, Mariano Duarte, Facundo Pelorosso, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 30
Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection
Rodolfo Guardado‐Mendoza, Miguel Angel Garcia-Magaña, Liz Jovanna Martínez-Navarro, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
Lingli Xie, Ziying Zhang, Qian Wang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 23
The role of electrolyte imbalances in predicting the severity of COVID-19 in the hospitalized patients: a cross-sectional study
Fatemeh Yasari, Meshkat Akbarian, Atefeh Abedini, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
Amanj Kurdi, Tanja Mueller, Natalie Weir
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 2
Open Access | Times Cited: 12
Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, et al.
Revista Portuguesa de Cardiologia (2023) Vol. 42, Iss. 4, pp. 373-383
Open Access | Times Cited: 7
Increased risk of acute kidney injury in coronavirus disease patients with renin–angiotensin–aldosterone-system blockade use: a systematic review and meta-analysis
Sul A Lee, Robin Park, Ji Hyun Yang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review
Lihua Qu, Chao Chen, Tong Yin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11483-11483
Open Access | Times Cited: 16
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease
Bertram Pitt, Rajiv Agarwal, Stefan D. Anker, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236123-e2236123
Open Access | Times Cited: 11
SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies
Mary G. Hornick, Margaret E. Olson, Arun L. Jadhav
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 1-12
Open Access | Times Cited: 13
New perspectives on angiotensin-converting enzyme 2 and its related diseases
Liping Liu, Xiaoli Zhang, Jian Li
World Journal of Diabetes (2021) Vol. 12, Iss. 6, pp. 839-854
Open Access | Times Cited: 12
Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection
Chang Chu, Anne Schönbrunn, Kristin Klemm, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy—effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker
Yingquan Xiong, Denis Delić, Shufei Zeng, et al.
BMC Nephrology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Risk Factors Associated with Mortality among Patients with COVID-19: Analysis of a Cohort of 1213 Patients in a Tertiary Healthcare Center
Carlos Romero-Gameros, Guadalupe Vargas‐Ortega, Mario Enrique Rendón Macías, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2780-2780
Open Access | Times Cited: 6
Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality
Malindu E. Fernando, Aaron Drovandi, Jonathan Golledge
Systematic Reviews (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Chronic use of renin‐angiotensin‐aldosterone system blockers and mortality in COVID‐19: A multicenter prospective cohort and literature review
Nathalie Gault, Marina Esposito‐Farèse, Matthieu Revest, et al.
Fundamental and Clinical Pharmacology (2021) Vol. 35, Iss. 6, pp. 1141-1158
Open Access | Times Cited: 7
Biomarkers, Pandemics and Host Response Treatment
David S. Fedson
Journal of Nursing & Healthcare (2024) Vol. 9, Iss. 2, pp. 01-15
Open Access
Adverse cardiovascular and kidney outcomes in people with SARS-CoV-2 treated with SGLT2 inhibitors
Taeyoung Choi, Yan Xie, Ziyad Al‐Aly
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access
The role of membrane and circulating forms of ACE 2 in pathological processes in COVID-19 infection
Yu. V. Cheburkin, Д. Л. Сонин, A. S. Polozov, et al.
Arterial’naya Gipertenziya (Arterial Hypertension) (2022) Vol. 27, Iss. 6, pp. 608-616
Open Access | Times Cited: 3
Drugs in primary care that may alter COVID-19 risk and severity
Brent Luu, Sampath Jeewantha Wijesinghe, Tarek Kassem, et al.
JAAPA (2023) Vol. 36, Iss. 5, pp. 28-33
Closed Access | Times Cited: 1
Effective therapy of hypertension from the standpoint of patient-centered medicine
В. И. Подзолков, Maria V. Vetluzhskaya, А. Е. Брагина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2023) Vol. 22, Iss. 4, pp. 3539-3539
Open Access | Times Cited: 1
Outcome of patients hospitalized for Covid‐19 and exposure to angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers in France: Results of the ACECoV study
Joachim Alexandre, Jean‐Luc Cracowski
Fundamental and Clinical Pharmacology (2020) Vol. 35, Iss. 1, pp. 192-193
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top